Nociceptin effects in the airways

Christian Peiser, Bradley J. Undem, Axel Fischer

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


The opioid-like heptadecapeptide nociceptin (NC) has the following effects in the airways (investigated in isolated tracheae and bronchi from guinea pig or rat): the electric field stimulation (EFS)-induces release of acetylcholine (ACh), the tachykinin substance P (SP) and calcitonin gene-related peptide (CGRP) is reduced after pretreatment with NC, and EFS-induced tachykinergic nonadrenergic-noncholinergic (NANC) bronchoconstriction is inhibited by NC. Both the NC-mediated inhibition of neurotransmission and of smooth muscle contraction occurred in a concentration-dependent manner. Because these effects were naloxone-insensitive, were blocked by the NC receptor antagonist [F/G]NC(1-13)NH2, and could be mimicked by the NC analogs, NCNH2 and NC(1-13)NH2, it is thought that they are distinct from the classic opioid receptors. That these pharmacological actions of NC are of relevance for airway physiology is highly probable given the presence of NC-immunoreactivity in the nerve fibers of the airways and of opioid-like receptor (ORL-1) transcripts in the jugular ganglia, from where the tachykinin-containing afferents arise. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)995-998
Number of pages4
Issue number7
StatePublished - Jul 2000

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Nociceptin effects in the airways'. Together they form a unique fingerprint.

Cite this